A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer
[Protocol 01-048] |
Chi, Dennis, MD |
A Phase I Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumors
[Protocol 09-154] |
Bell-McGuinn, Katherine, MD, PhD |
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106] |
Bell-McGuinn, Katherine, MD, PhD |
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155] |
O'Cearbhaill, Roisin, MB BCh BAO |
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184] |
Sabbatini, Paul, MD |
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] |
Keohan, Mary, MD |
A Phase I/II Study of Paclitaxel, Cisplatin, and ABT-888 (Velaparib) to Treat Advanced, Persistent, or Recurrent Cervical Cancer
[Protocol 11-131] |
Leitao, Mario, MD |
A Phase II Study of Bevacizumab with or without Everolimus to Treat Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-168] |
Tew, William, MD |
A Phase II Study of the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer
[Protocol 08-150] |
Kauff, Noah, MD |
A Phase II Study of TRC105 to Treat Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 11-165] |
Makker, Vicky, MD |
A Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Patients with Intermediate-Risk, Stage I/IIA Cervical Cancer Treated with Surgery
[Protocol 11-007] |
Leitao, Mario, MD |
A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
[Protocol 10-173] |
Leitao, Mario, MD |
A Phase III Study of Carboplatin and Paclitaxel Alone or with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
[Protocol 08-074] |
Leitao, Mario, MD |
A Phase III Study of Cisplatin and Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel Alone for Advanced Endometrial Carcinoma
[Protocol 09-145] |
Leitao, Mario, MD |
A Phase III Study of Docetaxel and Gemcitabine With or Without Bevacizumab in Women with Recurrent or Advanced Leiomyosarcoma of the Uterus
[Protocol 10-048] |
Hensley, Martee, MD |
A Phase III Study of Paclitaxel Every Three Weeks Versus Dose-Dense Weekly Paclitaxel in Combination with Carboplatin, with or without Bevacizumab, to Treat Stage III or IV Ovarian, Peritoneal, or Fallopian Tube Cancer
[Protocol 11-008] |
Leitao, Mario, MD |
A Pilot Study of a Polyvalent Vaccine Plus Bevacizumab in Patients with Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Second or Greater Remission
[Protocol 10-099] |
Sabbatini, Paul, MD |
A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease
[Protocol 07-029] |
Chi, Dennis, MD |
A Pilot Study Surveying Female Cancer Patients' Preference for Sexual Health Interventions
[Protocol 10-034] |
Carter, Jeanne, PhD |
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
[Protocol 05-001] |
Chi, Dennis, MD |
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051] |
Offit, Kenneth, MD |
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155] |
Chi, Dennis, MD |
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164] |
Tew, William, MD |
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184] |
O'Cearbhaill, Roisin, MB BCh BAO |
